Literature DB >> 30905864

Gelatin microspheres releasing transforming growth factor drive in vitro chondrogenesis of human periosteum derived cells in micromass culture.

Abhijith K Kudva1, Anna D Dikina2, Frank P Luyten3, Eben Alsberg4, Jennifer Patterson5.   

Abstract

For cartilage tissue engineering, several in vitro culture methodologies have displayed potential for the chondrogenic differentiation of mesenchymal stem cells (MSCs). Micromasses, cell aggregates or pellets, and cell sheets are all structures with high cell density that provides for abundant cell-cell interactions, which have been demonstrated to be important for chondrogenesis. Recently, these culture systems have been improved via the incorporation of growth factor releasing components such as degradable microspheres within the structures, further enhancing chondrogenesis. Herein, we incorporated different amounts of gelatin microspheres releasing transforming growth factor β1 (TGF-β1) into micromasses composed of human periosteum derived cells (hPDCs), an MSC-like cell population. The aim of this research was to investigate chondrogenic stimulation by TGF-β1 delivery from these degradable microspheres in comparison to exogenous supplementation with TGF-β1 in the culture medium. Microscopy showed that the gelatin microspheres could be successfully incorporated within hPDC micromasses without interfering with the formation of the structure, while biochemical analysis and histology demonstrated increasing DNA content at week 2 and accumulation of glycosaminoglycan and collagen at weeks 2 and 4. Importantly, similar chondrogenesis was achieved when TGF-β1 was delivered from the microspheres compared to controls with TGF-β1 in the medium. Increasing the amount of growth factor within the micromasses by increasing the amount of microspheres added did not further improve chondrogenesis of the hPDCs. These findings demonstrate the potential of using cytokine releasing, gelatin microspheres to enhance the chondrogenic capabilities of hPDC micromasses as an alternative to supplementation of the culture medium with growth factors. STATEMENT OF SIGNIFICANCE: Gelatin microspheres are utilized for growth factor delivery to enhance chondrogenesis of mesenchymal stem cells (MSCs) in high cell density culture systems. Herein, we employ a new combination of these microspheres with micromasses of human periosteum-derived cells, which possess ease of isolation, excellent expansion potential, and MSC-like differentiation capabilities. The resulting localized delivery of transforming growth factor β1 increases glycosaminoglycan and collagen production within the micromasses without exogenous stimulation in the medium. This unique combination is able to drive chondrogenesis up to similar levels as seen in micromasses that do receive exogenous stimulation. The addition of growth factor releasing microspheres to high cell density micromasses has the potential to reduce costs associated with this strategy for cartilage tissue engineering.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage tissue engineering; Gelatin microspheres; Growth factor delivery; High cell density culture; Mesenchymal stem cells

Mesh:

Substances:

Year:  2019        PMID: 30905864      PMCID: PMC6597958          DOI: 10.1016/j.actbio.2019.03.039

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  54 in total

1.  Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions.

Authors:  Holly A Leddy; Hani A Awad; Farshid Guilak
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2004-08-15       Impact factor: 3.368

2.  Tissue engineering strategies for cartilage generation--micromass and three dimensional cultures using human chondrocytes and a continuous cell line.

Authors:  Rahul S Tare; Daniel Howard; Jodie C Pound; Helmtrud I Roach; Richard O C Oreffo
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

Review 3.  Uncovering the periosteum for skeletal regeneration: the stem cell that lies beneath.

Authors:  Scott J Roberts; Nick van Gastel; Geert Carmeliet; Frank P Luyten
Journal:  Bone       Date:  2014-09-02       Impact factor: 4.398

4.  Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1.

Authors:  Loran D Solorio; Eran L Vieregge; Chirag D Dhami; Phuong N Dang; Eben Alsberg
Journal:  J Control Release       Date:  2011-11-10       Impact factor: 9.776

5.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells.

Authors:  B Johnstone; T M Hering; A I Caplan; V M Goldberg; J U Yoo
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

6.  RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation.

Authors:  Shiyou Chen; Michelle Crawford; Regina M Day; Victorino R Briones; Jennifer E Leader; Pedro A Jose; Robert J Lechleider
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

7.  Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2.

Authors:  Zarana S Patel; Masaya Yamamoto; Hiroki Ueda; Yasuhiko Tabata; Antonios G Mikos
Journal:  Acta Biomater       Date:  2008-04-22       Impact factor: 8.947

8.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow.

Authors:  A M Mackay; S C Beck; J M Murphy; F P Barry; C O Chichester; M F Pittenger
Journal:  Tissue Eng       Date:  1998

9.  Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis.

Authors:  S A Oberlender; R S Tuan
Journal:  Development       Date:  1994-01       Impact factor: 6.868

10.  Advancing osteochondral tissue engineering: bone morphogenetic protein, transforming growth factor, and fibroblast growth factor signaling drive ordered differentiation of periosteal cells resulting in stable cartilage and bone formation in vivo.

Authors:  L F Mendes; H Katagiri; W L Tam; Y C Chai; L Geris; S J Roberts; F P Luyten
Journal:  Stem Cell Res Ther       Date:  2018-02-21       Impact factor: 6.832

View more
  7 in total

Review 1.  Biomimetic hydrogels with spatial- and temporal-controlled chemical cues for tissue engineering.

Authors:  Weilue He; Max Reaume; Maureen Hennenfent; Bruce P Lee; Rupak Rajachar
Journal:  Biomater Sci       Date:  2020-06-03       Impact factor: 6.843

Review 2.  Bioengineering Approaches for Delivering Growth Factors: A Focus on Bone and Cartilage Regeneration.

Authors:  Sheeba Shakoor; Eleyna Kibble; Jehan J El-Jawhari
Journal:  Bioengineering (Basel)       Date:  2022-05-20

3.  Chondrogenesis of Mesenchymal Stem Cells through Local Release of TGF-β3 from Heparinized Collagen Biofabric.

Authors:  Hyungjin Jung; Phillip McClellan; Jean F Welter; Ozan Akkus
Journal:  Tissue Eng Part A       Date:  2021-06-14       Impact factor: 3.845

Review 4.  Strategies Using Gelatin Microparticles for Regenerative Therapy and Drug Screening Applications.

Authors:  Teruki Nii
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

5.  Microtissues from mesenchymal stem cells and siRNA-loaded cross-linked gelatin microparticles for bone regeneration.

Authors:  Sandra Hinkelmann; Alexandra H Springwald; Annett Starke; Hermann Kalwa; Christian Wölk; Michael C Hacker; Michaela Schulz-Siegmund
Journal:  Mater Today Bio       Date:  2021-12-17

Review 6.  Microcarriers in application for cartilage tissue engineering: Recent progress and challenges.

Authors:  Sheng-Long Ding; Xin Liu; Xi-Yuan Zhao; Ke-Tao Wang; Wei Xiong; Zi-Li Gao; Cheng-Yi Sun; Min-Xuan Jia; Cheng Li; Qi Gu; Ming-Zhu Zhang
Journal:  Bioact Mater       Date:  2022-01-25

7.  3D printed PCLA scaffold with nano-hydroxyapatite coating doped green tea EGCG promotes bone growth and inhibits multidrug-resistant bacteria colonization.

Authors:  Xiangchun Zhang; Jian He; Liang Qiao; Ziqi Wang; Qinqin Zheng; Chengdong Xiong; Hui Yang; Kainan Li; Chengyin Lu; Sanqiang Li; Hongping Chen; Xulin Hu
Journal:  Cell Prolif       Date:  2022-07-05       Impact factor: 8.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.